Characteristics and treatment patterns of older ms patients treated with peginterferon beta-1a or intramuscular interferon beta-1a in the real world

被引：0
|
作者：
Vignos, M. [1 ]
Altincatal, A. [1 ]
Mendoza, J. [1 ]
Avila, R. [1 ]
Makin, C. [1 ]
机构：
[1] Biogen, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0844
引用
收藏
页码：520 / 520
页数：1
相关论文
共 50 条
  • [1] Characteristics and clinical outcomes of older patients with ms treated with peginterferon beta-1a or intramuscular interferon beta-1a in ms paths
    Hua, L. H.
    Liao, S.
    Hersh, C.
    Fitzgerald, K.
    Altincatal, A.
    Naylor, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 519 - 520
  • [2] Real-world outcomes in patients with relapsing forms of multiple sclerosis treated with intramuscular interferon beta-1a or peginterferon beta-1a
    Salter, A.
    Lancia, S.
    Cutter, G.
    Fox, R.
    Marrie, R. A.
    Avila, R.
    Vignos, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 187 - 187
  • [3] Characteristics and clinical outcomes of underserved minority patients with multiple sclerosis treated with peginterferon beta-1a or intramuscular interferon beta-1a in MS PATHS
    Hersh, Carrie M.
    Fitzgerald, Kathryn
    Ryerson, Lana Zhovtis
    Mowry, Ellen
    Liao, Shirley
    Altincatal, Arman
    Naylor, Maria
    NEUROLOGY, 2021, 96 (15)
  • [4] Peginterferon beta-1a - a new form of interferon beta-1a
    Maciejek, Zdzislaw
    Niezgodzinska-Maciejek, Anna
    AKTUALNOSCI NEUROLOGICZNE, 2015, 15 (03): : 135 - 138
  • [5] A Matching-adjusted Indirect Comparison of Clinical Effectiveness of Subcutaneous Peginterferon Beta-1a and Intramuscular Interferon Beta-1a for the Treatment of Relapsing Multiple Sclerosis
    You, Xiaojun
    Scott, Thomas
    Shang, Shulian
    Evilevitch, Vladimir
    Sabetella, Guido
    Werneburg, Brian
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 415 - 415
  • [6] A Matching-adjusted Indirect Comparison of Clinical Effectiveness of Subcutaneous Peginterferon Beta-1a and Intramuscular Interferon Beta-1a for the Treatment of Relapsing Multiple Sclerosis
    Scott, Thomas
    Shang, Shulian
    Castrillo-Viguera, Carmen
    NEUROLOGY, 2017, 88
  • [7] Subacute thyroiditis in a patient with MS treated with interferon beta-1a
    Kreiss, Y
    Cohen, O
    Pras, E
    Achiron, A
    NEUROLOGY, 1999, 53 (07) : 1606 - 1606
  • [8] Interferon beta-1a prevents the outbreak of MS
    不详
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2011, 79 (02) : 128 - 129
  • [9] Treatment Satisfaction Increased over One Year When MS Patients Switched from an Interferon Beta Therapy to Peginterferon Beta-1a
    Hendin, Barry
    Naismith, Robert
    Wray, Sibyl
    Huang, Deren
    Dong, Qunming
    Jones, Daniel
    Watson, Crystal
    Jhaveri, Mehul
    NEUROLOGY, 2017, 88
  • [10] Interferon beta-1a as an investigational treatment for CIDP
    Vallat, JM
    Hahn, AF
    Léger, JM
    Cros, DP
    Magy, L
    Tabaraud, F
    Bouche, P
    Preux, PM
    NEUROLOGY, 2003, 60 (08) : S23 - S28
12345